MC
Muhlenkamp & Co Portfolio holdings
AUM
$320M
This Quarter Return
-2.07%
1 Year Return
+26.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(-4.5%)
Cap. Flow
-$4.1M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
49.51%
Holding
34
New
1
Increased
–
Reduced
27
Closed
2
Top Buys
| 1 |
EQC
Equity Commonwealth
EQC
|
$2.93M |
Top Sells
| 1 |
Biogen
BIIB
|
$6.31M |
| 2 |
NVTA
Invitae Corporation
NVTA
|
$216K |
| 3 |
Cameco
CCJ
|
$82.8K |
| 4 |
MasTec
MTZ
|
$46.7K |
| 5 |
Microchip Technology
MCHP
|
$27.6K |
Sector Composition
| 1 | Technology | 19.3% |
| 2 | Industrials | 17.47% |
| 3 | Healthcare | 15.47% |
| 4 | Consumer Discretionary | 14.84% |
| 5 | Financials | 11.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQC
26
DELISTED
Equity Commonwealth
EQC
| $2.93M | 1.13% |
+112,943
| New | +$2.93M |
|
27
Franco-Nevada
FNV
$36.7B
| $2.71M | 1.04% |
20,853
-29
| -0.1% | -$3.77K |
|
28
Royal Gold
RGLD
$12B
| $2.33M | 0.89% |
24,350
-33
| -0.1% | -$3.15K |
|
29
Morgan Stanley
MS
$238B
| $1.05M | 0.4% |
10,805
| – | – |
|
30
Pfizer
PFE
$142B
| $1.05M | 0.4% |
24,379
| – | – |
|
31
Enterprise Products Partners
EPD
$69.3B
| $538K | 0.21% |
24,855
| – | – |
|
32
Rush Enterprises Class B
RUSHB
$4.48B
| $309K | 0.12% |
6,742
-232
| -3% | -$10.6K |
|
|
33
Biogen
BIIB
$20.5B
| – | – |
-18,218
| Closed | -$6.31M |
|
|
NVTA
34
DELISTED
Invitae Corporation
NVTA
| – | – |
-6,390
| Closed | -$216K |
|